Hrkac Frederick 4
4 · BioSig Technologies, Inc. · Filed Jun 21, 2022
Insider Transaction Report
Form 4
Hrkac Frederick
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-05-12+50,000→ 50,000 totalExercise: $0.82Exp: 2032-05-12→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]50% of the shares underlying this stock option vested and became exercisable immediately on the date of grant and 50% will vest and become exercisable on the first anniversary of the date of the director appointment on April 28, 2022, provided Mr. Hrkac is still serving as a director on such date and subject to the terms and conditions of the BioSig Technologies, Inc. 2012 Equity Incentive Plan.